Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Aldeyra Therapeu
(NQ:
ALDX
)
6.130
-0.190 (-3.01%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 6, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Aldeyra Therapeu
< Previous
1
2
3
4
5
Next >
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 02, 2021
Gainers Bone Biologics (NASDAQ:BBLG) shares rose 33.57% to $7.32 during Tuesday's pre-market session. The company's market cap stands at $224.5 million. Artelo...
Via
Benzinga
Aldeyra Therapeutics (ALDX) Q3 2021 Earnings Call Transcript
October 29, 2021
ALDX earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug
October 28, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Corvus' China Partner Approved For Early Stage Study Of CPI-818 In...
Via
Benzinga
The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO
August 05, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (...
Via
Benzinga
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
May 01, 2021
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...
Via
Benzinga
Exposures
Product Safety
Aldeyra Therapeutics (ALDX) Q2 2021 Earnings Call Transcript
August 07, 2021
ALDX earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Aldeyra Secures US Orphan Drug Tag For Its Retinitis Pigmentosa Candidate
August 04, 2021
The FDA has granted orphan drug designation to Aldeyra Therapeutics Inc's (NASDAQ: ALDX) ADX-2191 to treat retinitis pigmentosa (RP). ADX-2191 is a...
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
August 04, 2021
Gainers BeyondSpring (NASDAQ:BYSI) stock increased by 337.79% to $42.16 during Wednesday's pre-market session. The market value of their outstanding shares is at $1.6...
Via
Benzinga
Aldeyra Stock Trading Higher On FDA Orphan Drug Tag For Primary Vitreoretinal Lymphoma Candidate
July 20, 2021
The FDA has granted Orphan Drug Designation to Aldeyra Therapeutics Inc's (NASDAQ: ALDX) ADX-2191 (methotrexate for intravitreal injection) for primary...
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Monday's Pre-Market Session
July 19, 2021
Gainers NRX Pharmaceuticals (NASDAQ:NRXP) stock moved upwards by 67.6% to $14.28 during Monday's pre-market session. The company's market cap stands at $684.2...
Via
Benzinga
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
August 01, 2021
Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results....
Via
Benzinga
Exposures
Product Safety
The Past Week's Notable Insider Buys: Amphenol, Aldeyra, Werewolf Therapeutics, And More
May 08, 2021
Insider buying can be an encouraging signal for investors, especially when markets are near all-time highs. Some insiders have taken advantage of initial public offerings. A few chief executive...
Via
Talk Markets
The Past Week's Notable Insider Buys: Amphenol, Aldeyra, Werewolf Therapeutics And More
May 08, 2021
Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. Once again, some insiders have taken advantage of initial...
Via
Benzinga
Aldeyra Therapeutics (ALDX) Q1 2021 Earnings Call Transcript
May 06, 2021
ALDX earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
12 Health Care Stocks Moving In Thursday's Pre-Market Session
April 29, 2021
Gainers Galera Therapeutics (NASDAQ:GRTX) shares increased by 42.2% to $9.4 during Thursday's pre-market session. The market value of their outstanding shares is at $...
Via
Benzinga
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom
May 06, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Exposures
Product Safety
60 Biggest Movers From Yesterday
April 29, 2021
Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) shares gained 75.6% to settle at $43.73 on Wednesday. The company recently said it paid $1 million towards acquisition of...
Via
Benzinga
Why Aldeyra Therapeutics Stock Is Sinking Today
April 28, 2021
The company plans to conduct a public stock offering.
Via
The Motley Fool
41 Stocks Moving In Wednesday's Mid-Day Session
April 28, 2021
Gainers Aurora Mobile Limited (NASDAQ: JG) shares climbed 21.3% to $4.27 after Oppenheimer initiated coverage on the stock with an Outperform rating and a price target of $6 per...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
April 28, 2021
Gainers Akari Therapeutics (NASDAQ:AKTX) stock moved upwards by 14.1% to $2.67 during Wednesday's pre-market session. The company's market cap stands at $102.7...
Via
Benzinga
The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping
April 28, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) Aldeyra Therapeutics, Inc...
Via
Benzinga
Exposures
Product Safety
25 Stocks Moving in Wednesday's Pre-Market Session
April 28, 2021
Gainers RiceBran Technologies (NASDAQ: RIBT) rose 16.1% to $1.37 in pre-market trading after jumping around 27% on Tuesday. The company is scheduled to report Q1 earnings today....
Via
Benzinga
Aldeyra Seeks To Raise $125M Via Equity To Support Reproxalap US Application
April 28, 2021
Aldeyra Therapeutics Inc (NASDAQ: ALDX) intends to sell $125 million shares of its common stock in an underwritten public offering. Underwriters will...
Via
Benzinga
Mid-Afternoon Market Update: TrueBlue Rises Following Q1 Earnings; RealNetworks Shares Slide
April 27, 2021
Toward the end of trading Tuesday, the Dow traded down 0.02% to 33,975.58 while the NASDAQ fell 0.34% to 14,090.03. The S&P also fell, dropping 0.05% to 4,185.36. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Tuesday's Intraday Session
April 27, 2021
Gainers Vaxart (NASDAQ:VXRT) shares moved upwards by 53.38% to $9.29 during Tuesday's regular session. Vaxart's stock is trading at a volume of 115.1 million...
Via
Benzinga
52 Biggest Movers From Yesterday
April 28, 2021
Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) gained 51.2% to close at $24.90 on Tuesday. Urban Tea, Inc. (NASDAQ: MYT) rose 38.1% to settle at $4.64. Vaxart, Inc. (...
Via
Benzinga
Mid-Day Market Update: Crude Oil Rises 1%; PQ Group Shares Plummet
April 27, 2021
Midway through trading Tuesday, the Dow traded down 0.08% to 33,955.78 while the NASDAQ fell 0.30% to 14,096.16. The S&P also fell, dropping 0.09% to 4,183.81. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Cyclerion, Sol-Gel, Aldeyra, DermTech and Bionano Genomics Are Moving Today
April 27, 2021
Cyclerion Therapeutics, Inc. (NASDAQ: CYCN), Sol-Gel Technologies Ltd. (NASDAQ: SLGL), Aldeyra Therapeutics, Inc. (NASDAQ: ALDX), DermTech, Inc. (NASDAQ: DMTK) and Bionano...
Via
Benzinga
38 Stocks Moving In Tuesday's Mid-Day Session
April 27, 2021
Gainers RiceBran Technologies (NASDAQ: RIBT) shares jumped 60.8% to $1.4950. RiceBran Technologies is scheduled to host a conference call on April 28th to discuss its Q1...
Via
Benzinga
Why Aldeyra Therapeutics Stock Is Soaring Today
April 27, 2021
The company reported great clinical results for its lead pipeline candidate.
Via
The Motley Fool
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.